Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3

Sponsor Class

NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 1

Conditions

Sarcoma 6Cardiotoxicity 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 3Neuroblastoma 2Leukemia 2Vomiting 1Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma, Synovial 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrence 1Osteosarcoma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Nausea 1Lymphoma, Large-Cell, Anaplastic 1Localized Extraskeletal Ewing Sarcoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Ganglioneuroblastoma 1Fibrosarcoma 1Extravasations of Anthracycline Anti-cancer Agents 1Extravasation 1Drug-Related Side Effects and Adverse Reactions 1Dermatofibrosarcoma 1Degradation of Top2b and Top2a in Human by Dexrazoxane 1

Interventions

Cyclophosphamide 282Rituximab 260Etoposide 161Filgrastim 155Vincristine 145Doxorubicin 134Prednisone 117Cytarabine 108Radiotherapy 102Peripheral Blood Stem Cell Transplantation 90Methotrexate 90fludarabine phosphate 87Melphalan 78Busulfan 71Dexamethasone 59Granulocyte Colony-Stimulating Factor 56Carmustine 53fludarabine 51Bortezomib 46Tacrolimus 44Mycophenolic Acid 41Antilymphocyte Serum 41Ifosfamide 40Leucovorin 39Gemcitabine 38Whole-Body Irradiation 36Cyclosporine 35Bendamustine Hydrochloride 34sargramostim 33Methylprednisolone 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Lymphoma × Dexrazoxane × Clear all
NCT00005578 2014-07-24

Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease

Children's Oncology Group

Phase 3 Completed
219 enrolled
Lymphoid

Lymphoma, Cardiotoxicity

NCT00002827 2013-08-26

Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease

Children's Oncology Group

Phase 3 Completed
294 enrolled
Lymphoid

Lymphoma, Cardiotoxicity

NCT01230983 2013-06-06

T-Cell #4

Children's Oncology Group

Phase 3 Completed
573 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡